Sclerosing Rhabdomyosarcoma
1 clinical trials · Condition
◉ Watch Sclerosing Rhabdomyosarcoma
| Record | Firm | Date |
|---|---|---|
| Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma (NCT02567435) | National Cancer Institute (NCI) | 2016-06-01 |
Track Sclerosing Rhabdomyosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.